Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk Between Invariant NKT Cells and Dendritic Cells

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.00886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Ligand-Dependent Induction of Noninflammatory Dendritic Cells by Anergic Invariant NKT Cells Minimizes Autoimmune Inflammation

Journal of Immunology
AllergyImmunology
2008English

Ligand-Dependent Induction of Noninflammatory Dendritic Cells by Anergic Invariant NKT Cells Minimizes Autoimmune Inflammation

Journal of Immunology
AllergyImmunology
2008English

Immune Regulation by Invariant NKT Cells in Autoimmunity

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Invariant NKT Cells Provide Innate and Adaptive Help for B Cells

Current Opinion in Immunology
AllergyImmunology
2014English

Invariant NKT Cells Inhibit Development of the Th17 Lineage

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

The Regulatory Role of Invariant NKT Cells in Tumor Immunity

Cancer immunology research
Cancer ResearchImmunology
2015English

Regulation of the Bi-Directional Cross-Talk Between Ovarian Cancer Cells and Adipocytes by SPARC

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Exploiting Dendritic Cells to Improve Vaccine Efficacy

Journal of Clinical Investigation
Medicine
2002English

Budesonide Modulates the Immune Cross-Talk Between Mononuclear and Colon Cancer Cells

International Journal of Immunology and Immunotherapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy